{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:07Z","timestamp":1787020147853,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003062","name":"Erciyes \u00dcniversitesi","doi-asserted-by":"publisher","award":["TSA-2013-4583"],"award-info":[{"award-number":["TSA-2013-4583"]}],"id":[{"id":"10.13039\/501100003062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hj\u00e4rt-Lungfonden (SE)"},{"DOI":"10.13039\/501100011898","name":"Marianne och Marcus Wallenbergs stiftelse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12882-016-0406-4","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T23:41:51Z","timestamp":1480462911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vasopressin-related copeptin is a novel predictor of early endothelial dysfunction in patients with adult polycystic kidney disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Ismail","family":"Kocyigit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut Ilker","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eray","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydin","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozcan","family":"Orscelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Tokgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sipahioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jes\u00fas","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oktay","family":"Oymak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7377-9356","authenticated-orcid":false,"given":"Jonas","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,30]]},"reference":[{"issue":"10","key":"406_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrneph.2015.128","volume":"11","author":"RD Perrone","year":"2015","unstructured":"Perrone RD, Malek AM, Watnick T. Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2015;11(10):589\u201398.","journal-title":"Nat Rev Nephrol"},{"key":"406_CR2","doi-asserted-by":"publisher","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","volume":"29 Suppl 4","author":"EM Spithoven","year":"2014","unstructured":"Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, Arest\u00e9 N, de la Torre RA, Caskey F, Couchoud C, Finne P, Heaf J, Hoitsma A, de Meester J, Pascual J, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT, ERA-EDTA Registry; EuroCYST Consortium; WGIKD. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant. 2014;29 Suppl 4:iv15\u201325.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"406_CR3","doi-asserted-by":"publisher","first-page":"F1005","DOI":"10.1152\/ajprenal.00243.2011","volume":"301","author":"GA Reif","year":"2011","unstructured":"Reif GA, Yamaguchi T, Nivens E, Fujiki H, Pinto CS, Wallace DP. Tolvaptan inhibits ERK-dependent cell proliferation, Cl\u2212 secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin. Am J Physiol Renal Physiol. 2011;301(5):F1005\u201313.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"406_CR4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1681\/ASN.2015010047","volume":"27","author":"CS Pinto","year":"2016","unstructured":"Pinto CS, Raman A, Reif GA, Magenheimer BS, White C, Calvet JP, Wallace DP. Phosphodiesterase isoform regulation of cell proliferation and fluid secretion in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27(4):1124\u201334.","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"406_CR5","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, TEMPO 3:4 Trial Investigators. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407\u201318.","journal-title":"N Engl J Med"},{"issue":"2 Pt 2","key":"406_CR6","doi-asserted-by":"publisher","first-page":"I129","DOI":"10.1161\/01.HYP.5.2_Pt_2.I129","volume":"5","author":"JJ Preibisz","year":"1983","unstructured":"Preibisz JJ, Sealey JE, Laragh JH, Cody RJ, Weksler BB. Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension. 1983;5(2 Pt 2):I129\u201338.","journal-title":"Hypertension"},{"issue":"1","key":"406_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","volume":"52","author":"NG Morgenthaler","year":"2006","unstructured":"Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006;52(1):112\u20139.","journal-title":"Clin Chem"},{"issue":"2","key":"406_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.11613\/BM.2013.021","volume":"23","author":"L Dobsa","year":"2013","unstructured":"Dobsa L, Edozien KC. Copeptin and its potential role in diagnosis and prognosis of various diseases. Biochem Med (Zagreb). 2013;23(2):172\u201390.","journal-title":"Biochem Med (Zagreb)"},{"key":"406_CR9","first-page":"2","volume":"24","author":"GP Mavani","year":"2015","unstructured":"Mavani GP, DeVita MV, Michelis MF. A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin. Front Med (Lausanne). 2015;24:2\u201319.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"406_CR10","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1093\/ndt\/gfs070","volume":"27","author":"WE Boertien","year":"2012","unstructured":"Boertien WE, Meijer E, Zittema D, van Dijk MA, Rabelink TJ, Breuning MH, Struck J, Bakker SJ, Peters DJ, de Jong PE, Gansevoort RT. Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2012;27(11):4131\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"406_CR11","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2215\/CJN.08690813","volume":"9","author":"D Zittema","year":"2014","unstructured":"Zittema D, van den Berg E, Meijer E, Boertien WE, Muller Kobold AC, Franssen CF, de Jong PE, Bakker SJ, Navis G, Gansevoort RT. Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol. 2014;9(9):1553\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"key":"406_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009;20:205\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"406_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1373\/clinchem.2005.0525144","volume":"52","author":"GL Myers","year":"2006","unstructured":"Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, et al. National kidney disease education program laboratory working group: recommendations for improving serum creatinine measurement: a report from the laboratory working group of the national kidney disease education program. Clin Chem. 2006;52:5\u201318.","journal-title":"Clin Chem"},{"key":"406_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","volume":"55","author":"RB Devereux","year":"1977","unstructured":"Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613\u20138.","journal-title":"Circulation"},{"key":"406_CR15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/0735-1097(93)90203-D","volume":"22","author":"DS Celermajer","year":"1993","unstructured":"Celermajer DS, Sorensen K, Ryalls M, et al. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol. 1993;22:854\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"406_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000339440","volume":"36","author":"I Kocyigit","year":"2012","unstructured":"Kocyigit I, Kaya MG, Orscelik O, Kaya C, Akpek M, Zengin H, Sipahioglu MH, Unal A, Yilmaz MI, Tokgoz B, Oymak O, Axelsson J. Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients. Am J Nephrol. 2012;36(1):11\u20138.","journal-title":"Am J Nephrol"},{"issue":"3-4","key":"406_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000353730","volume":"123","author":"I Kocyigit","year":"2013","unstructured":"Kocyigit I, Yilmaz MI, Orscelik O, Sipahioglu MH, Unal A, Eroglu E, Kalay N, Tokgoz B, Axelsson J, Oymak O. Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease. Nephron Clin Pract. 2013;123(3-4):157\u201364.","journal-title":"Nephron Clin Pract"},{"issue":"8","key":"406_CR18","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1093\/ndt\/gfp136","volume":"24","author":"PJ Azurmendi","year":"2009","unstructured":"Azurmendi PJ, Fraga AR, Galan FM, Kotliar C, Arrizurieta EE, Valdez MG, Forcada PJ, Stefan JS, Martin RS. Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function. Nephrol Dial Transplant. 2009;24(8):2458\u201363.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"406_CR19","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.V1181371","volume":"11","author":"D Wang","year":"2000","unstructured":"Wang D, Iversen J, Strandgaard S. Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2000;11(8):1371\u20136.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"406_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000354236","volume":"38","author":"KM Peterson","year":"2013","unstructured":"Peterson KM, Franchi F, Loeffler DL, Psaltis PJ, Harris PC, Lerman LO, Lerman A, Rodriguez-Porcel M. Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease. Am J Nephrol. 2013;38(3):233\u201340.","journal-title":"Am J Nephrol"},{"issue":"2","key":"406_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ki.2014.241","volume":"87","author":"A Lorthioir","year":"2015","unstructured":"Lorthioir A, Joannid\u00e8s R, R\u00e9my-Jouet I, Fr\u00e9guin-Bouilland C, Iacob M, Roche C, Monteil C, Lucas D, Renet S, Audr\u00e9zet MP, Godin M, Richard V, Thuillez C, Guerrot D, Bellien J. Polycystin deficiency induces dopamine-reversible alterations in flow-mediated dilatation and vascular nitric oxide release in humans. Kidney Int. 2015;87(2):465\u201372.","journal-title":"Kidney Int"},{"issue":"8","key":"406_CR22","first-page":"1332","volume":"10","author":"JN Barendregt","year":"1995","unstructured":"Barendregt JN, Florijn KW, Muizert Y, Chang PC. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion. Nephrol Dial Transplant. 1995;10(8):1332\u201341.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"406_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/HYPERTENSIONAHA.111.172080","volume":"58","author":"S Abdul-Majeed","year":"2011","unstructured":"Abdul-Majeed S, Nauli SM. Dopamine receptor type 5 in the primary cilia has dual chemo- and mechano-sensory roles. Hypertension. 2011;58(2):325\u201331.","journal-title":"Hypertension"},{"issue":"4","key":"406_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1046\/j.1523-1755.2003.00242.x","volume":"64","author":"JJ Grantham","year":"2003","unstructured":"Grantham JJ. Lillian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease. Understanding polycystic kidney disease: A systems biology approach. Kidney Int. 2003;64(4):1157\u201362.","journal-title":"Kidney Int"},{"key":"406_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","volume":"66","author":"FA Belibi","year":"2004","unstructured":"Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, Helmkamp Jr GM, Grantham JJ. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 2004;66:964\u201373.","journal-title":"Kidney Int"},{"issue":"4","key":"406_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000326902","volume":"34","author":"E Meijer","year":"2011","unstructured":"Meijer E, Boertien WE, Zietse R, Gansevoort RT. Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease. Kidney Blood Press Res. 2011;34(4):235\u201344.","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"406_CR27","doi-asserted-by":"publisher","first-page":"F761","DOI":"10.1152\/ajprenal.00247.2010","volume":"300","author":"M Boone","year":"2011","unstructured":"Boone M, Kortenoeven ML, Robben JH, Tamma G, Deen PM. Counteracting vasopressin-mediated water reabsorption by ATP, dopamine, and phorbol esters: mechanisms of action. Am J Physiol Renal Physiol. 2011;300(3):F761\u201371.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"406_CR28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.7326\/0003-4819-159-6-201309170-00004","volume":"7159","author":"KF Erickson","year":"2011","unstructured":"Erickson KF, Chertow GM, Goldhaber-Fiebert JD. Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med. 2011;7159(6):382\u20139.","journal-title":"Ann Intern Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-016-0406-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-016-0406-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-016-0406-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T11:30:48Z","timestamp":1657884648000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-016-0406-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,30]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["406"],"URL":"https:\/\/doi.org\/10.1186\/s12882-016-0406-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,30]]},"article-number":"196"}}